MW
Markus Warmuth
Venture Partner at Versant Ventures
Cambridge, Massachusetts
Overview
Markus Warmuth is the Chief Executive Officer at Monte Rosa Therapeutics in Cambridge, Massachusetts, with a background in biotechnology and drug discovery. Notable highlights of his career include serving as the President and Chief Executive Officer at H3 Biomedicine and leading drug discovery efforts at Novartis Institutes for BioMedical Research.
Work Experience
Member Board Of Directors
2021 - Current
Ventus Therapeutics develops small molecule drugs that target autoimmune diseases, inflammatory diseases, and cancer.
Raised $370,150,000.00 from Michael J. Fox Foundation.
Chief Executive Officer
2019
Venture Partner
2019
Versant Ventures caters to the healthcare sector with early and later stage venture, private equity, and debt financing investments.
Independent Board Member
2018 - 2023
Entrepreneur In Residence
2018 - 2019
Independent Board Member
2017 - 2018
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Raised $1,400,000,000.00 from Nextech Invest.
President and Chief Executive Officer
2011 - 2018
Chief Scientific Officer
2011 - 2011
Executive Director and Head of Oncology Drug Dicovery
2008 - 2011
Director Kinase Platform
2002 - 2008
MD
1998 - 2002
Medical Oncologist and Principal Investigator
Education
MD
1991 - 1998